Upgrade to SI Premium - Free Trial

Bill Ackman said Valeant Pharma (VRX) worth $180-$240 Near-Term, $262-$350 Long-Term

October 30, 2015 10:14 AM
On the Valeant Pharma ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Hedge Funds Short Sales Trader Talk

Next Articles